Abstract
Background: The SARS-CoV-2 virus is responsible for the COVID-19 pandemic. To better understand the evolution of SARS-CoV-2 early in the pandemic in the Province of Cordoba, Argentina, we performed a comparative genomic analysis of SARS-CoV-2 strains detected in survivors and non-survivors of COVID-19. We also carried out an epidemiological study to find a possible association between the symptoms and comorbidities of these patients with their clinical outcomes.
Results: A representative sampling was performed in different cities in the Province of Cordoba. Ten and nine complete SARS-CoV-2 genomes were obtained by next-generation sequencing of nasopharyngeal specimens from non-survivors and survivors, respectively. Phylogenetic and phylodynamic analyses revealed multiple introductions of the most common lineages in South America, including B.1, B.1.1.1, B.1.499, and N.3. Fifty-six mutations were identified, with 14% of those in common between the non-survivor and survivor groups. Specific SARS-CoV-2 mutations for survivors constituted 25% whereas for non-survivors they were 41% of the repertoire, indicating partial selectivity. The non-survivors’ variants showed higher diversity in 9 genes, with a majority in Nsp3, while the survivors’ variants were detected in 5 genes, with a higher incidence in the Spike protein. At least one comorbidity was present in 60% of non-survivor patients and 33% of survivors. Age 75-85 years (p = 0.018) and hospitalization (p = 0.019) were associated with non-survivor patients. Related to the most common symptoms, the prevalence of fever was similar in both groups, while dyspnea was more frequent among non-survivors and cough among survivors.
Conclusions: This study describes the association of clinical characteristics with the clinical outcomes of survivors and non-survivors of COVID-19 patients, and the specific mutations found in the genome sequences of SARS-CoV-2 in each patient group. Future research on the functional characterization of novel mutations should be performed to understand the role of these variations in SARS-CoV-2 pathogenesis and COVID-19 disease outcomes. These results add new genomic data to better understand the evolution of the SARS-CoV-2 variants that spread in Argentina during the first wave of the COVID-19 pandemic.
Keywords: COVID-19; Comparative genomics; Genomes; Infectious diseases; Molecular epidemiology; SARS-CoV-2; Sequencing; Severe acute respiratory syndrome coronavirus 2.
【저자키워드】 COVID-19, SARS-CoV-2, Infectious diseases, Sequencing, Severe acute respiratory syndrome coronavirus 2., Comparative genomics, Molecular epidemiology, genomes, 【초록키워드】 severe acute respiratory syndrome coronavirus 2, Evolution, coronavirus, pandemic, Mutation, Infectious diseases, Hospitalization, Clinical characteristics, COVID-19 pandemic, Variation, Sequencing, variant, Comorbidities, Comorbidity, SARS-CoV-2 virus, Symptom, severe acute respiratory syndrome Coronavirus, cough, Symptoms, clinical outcomes, Spike protein, COVID-19 disease, Clinical outcome, Spread, Prevalence, outcomes, Protein, Survivors, SARS-CoV-2 variants, SARS-CoV-2 genome, Fever, Next-generation sequencing, Comparative genomics, Dyspnea, Research, Patient, Molecular epidemiology, Lineage, Evolution of SARS-CoV-2, Genomic analysis, phylodynamic, genomes, Nsp3, incidence, SARS-CoV-2 mutation, respiratory, South America, First wave, SARS-CoV-2 pathogenesis, patients, COVID-19 patients, association, genome sequence, Genome sequences, B.1, Comparative, Non-survivors, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, both groups, SARS-CoV-2 genomes, genomic data, specific mutations, SARS-CoV-2 strains, Epidemiological study, repertoire, Specific, SARS-CoV-2 strain, nasopharyngeal specimen, survivor, Córdoba, Future, Genes, Complete, non-survivor, responsible, performed, carried, nine, was performed, functional, majority, analysis, groups, specific mutation, the Spike, in both groups, the SARS-CoV-2, 【제목키워드】 Analysis, COVID-19 patient, survivor,